The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9% rootsanalysis.com

james hebrew 11 months ago in Health

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes. Roots Analysis has announced the addition of “CD-47 Therapeutics Market, 2021-2035” report to its list of offerings.   In recent years, the focus of the research community has shifted towards the development of…